title: Keratinocytes in the treatment of severe burn injury: an update.
abstract: Burns are among the most life-threatening physical injuries, in which fast wound closure is crucial. The surgical burn care has evolved considerably throughout the past decennia resulting in a shift of therapeutic goals. Therapies aiming to provide coverage of the burn have been replaced by treatments that have both functional as aesthetic outcomes. The standard in treating severe burns is still early excision followed by skin grafting. The use of cultured keratinocytes to cover extensive burn wounds appeared very promising at first, but the technique still has several limitations of which the long time to culture, the major costs, the risk of infection and the need for an adequate dermal layer limit clinical application. The introduction of dermal substitutes, composite grafts, tissue engineering based on stem cell application have been advocated. The aim of this review is to assess the use of cultured keratinocytes in terms of technical aspects, clinical application, limitations and future perspectives. Cultured keratinocytes are expected to keep playing a role in wound healing, especially in the field of chronic wounds. In severe burns, despite its limitations, keratinocytes can be beneficial if implemented as one of the elements in a broader wound management.
authors.affiliation: Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
authors.forename: Liesbeth
authors.initials: L
authors.lastname: Lootens
authors.forename: Nele
authors.initials: N
authors.lastname: Brusselaers
authors.forename: Hilde
authors.initials: H
authors.lastname: Beele
authors.forename: Stan
authors.initials: S
authors.lastname: Monstrey
mesh_terms: D002056:Burns / Q000628:therapy*; D018929:Cell Culture Techniques; D002478:Cells, Cultured; D002921:Cicatrix / Q000517:prevention & control; D048091:Guided Tissue Regeneration; D006801:Humans; D015603:Keratinocytes; D016038:Skin Transplantation; D017768:Skin, Artificial / Q000009:adverse effects / Q000191:economics; D023822:Tissue Engineering / Q000379:methods*; D016896:Treatment Outcome